Radiation absorbed dose estimates for Indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 671-676

  Mardirossian, George ^a   Brill, A Bertrand ^b   Harwood, Steven J ^b   Olsen, John ^b   Dwyer, Karen A ^b   Siegel, Jeffry A ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Colorectal cancer; Indium 111 labeled B72.3; MIRD dose estimate report; Ovarian cancer

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INDIUM 111; MONOCLONAL ANTIBODY B.72.3 IN 111; ONCOSCINT; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CLEARANCE; COLORECTAL CANCER; DOSE RESPONSE; DOSIMETRY; FEMALE; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; OVARY CANCER; PRIORITY JOURNAL; RADIATION ABSORPTION; SERODIAGNOSIS;

ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; OLIGOPEPTIDES; OVARIAN NEOPLASMS; PENTETIC ACID; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; TISSUE DISTRIBUTION;

EID: 0031946028     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rodwell JD, Alvarez VL, Lee C, et al. Site-specific covalent modification of monoclonal antibodies. In vivo and in vitro evaluations. Proc Natl Acad Sci USA 1986;83:2632-2636.
2. Johnson VG, Schlom J, Paterson AJ, Bennett J, Mangani JL, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986;46:3118-3124.
3. 111In CYT-103. Princeton, NJ: Cytogen Corp.; 1989.
4. 111In CYT-103 efficacy data for patients with colorectal carcinoma. Princeton, NJ: Cytogen Corp.; 1989.
5. 111In-CYT-103 in human. Princeton, NJ: Cytogen Corp.; 1990.
6. Waldmann TA, Strober W. Metabolism of immunoglobulins. Progr Allergy 1969;13: 1-110.
7. Weber DA, Eckerman KF, Dillman LT, Ryman JC. MIRD radionuclide data and decay schemes. New York: Society of Nuclear Medicine; 1989.
8. Doherty P, Schwinger R, King M, Gionet M. Distribution and dosimetry of indium-111-labeled F(ab′)2 fragments in humans. In: Fourth International Radiopharmaceutical Symposium, CONF-851113(DES6010102). Oak Ridge, TN: Oak Ridge Associated Universities; 1985:464-476.
9. Stabin MG. Prediction of radiation dose to the GI tract from analysis of blood and liver time-activity curves. In: Fifth International Radiopharmaceutical Dosimetry Symposium, CONF-910529. Oak Ridge, TN: Oak Ridge Associated Universities; 1992:202-215.
10. International Commission on Radiation Protection Limits for Intake of Radionuclides by Workers. ICRP publication 30. New York: Pergamon Press; 1979:30-34.
11. Eckerman K. Dosimetric methodology of the ICRP. In: Raabe OG, ed. Internal radiation dosimetry. Health Physics Society 1994 Summer School. Madison, WI: Medical Physics Publishing; 1994.
12. Mozley PD, Stubbs JB, Kung, HF, et al. Biodistribution and dosimetry of iodine-123-IBF: a potential radioligand for imaging the D2 dopamine receptor. J Nucl Med 1993;34:1910-1917.
13. Watson E, Stabin MG. Basic alternative software package for internal radiation dose calculations. In: Katheren RL, Higby DP, McKinney MA, eds. Computer applications in health physics. Richland, WA: Proceedings of the 17th Midyear Topical Symposium of the Health Physics Society; 1984.
14. Report of the Task Group on Reference Man. ICRP Publication 23. New York: Pergamon Press; 1975.
15. Poston JW, Aissi A, Hui TY, Jimba BM. A preliminary model of the circulating blood for use in radiation dose calculations. In: Fourth International Radiopharmaceutical Dosimetry Symposium, CONF-851113. Oak Ridge, TN: Oak Ridge Associated Universities; 1985:574-586.
16. Berman M, Beltz WF, Greif PC, Chabay R, Boston RC. CONSAM user's guide. Bethesda, MD: Laboratory of Mathematical Biology, National Institutes of Health; 1983.
17. Berman M, Schoenfield R. Invariants in experimental data on linear kinetics and the formulation of models. J Appl Physics 1956;27:1361-1370.
18. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York: Society of Nuclear Medicine; 1988.
19. Snyder WS, Ford MR, Warner GG. MIRD Pamphlet No. 5. revised: estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. New York: Society of Nuclear Medicine; 1987.
20. Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. I. Methods. ORNL/TM-8381/V1. Oak Ridge, TN: Oak Ridge National Laboratory: 1987.